$ENDV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDONOVO THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENDONOVO THERAPEUTICS, INC.. Get notifications about new insider transactions in ENDONOVO THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 35 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 32 | 21,154,123 | 21.2 M to 21.2 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 74 | 21,152,123 | 21.1 M to 21.2 M (+0.02 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 31 | 21,147,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 148 | 21,145,123 | 21.1 M to 21.1 M (+0.05 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 147 | 21,135,123 | 21.1 M to 21.1 M (+0.05 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 74 | 21,125,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 29 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 30 | 21,120,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 59 | 21,116,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,111,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,109,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,104,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,099,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 58 | 21,094,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,089,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,087,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 62 | 21,085,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 25 | 21,080,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 61 | 21,078,123 | 21.1 M to 21.1 M (+0.02 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 117 | 21,073,123 | 21.1 M to 21.1 M (+0.05 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,063,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Sell | P | 0.01 | 2,000 | 27 | 21,061,123 | 21.1 M to 21.1 M (-0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 21,063,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,061,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,059,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 21,057,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,055,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,053,123 | 21.1 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,051,123 | 21 M to 21.1 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 26 | 21,049,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 29 | 21,047,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 29 | 21,045,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 29 | 21,043,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 12,000 | 167 | 21,041,123 | 21 M to 21 M (+0.06 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 32 | 21,029,123 | 21 M to 21 M (+0.01 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 160 | 21,027,123 | 21 M to 21 M (+0.05 %) |
Apr 24 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 33 | 21,017,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 34 | 21,015,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 35 | 21,013,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 34 | 21,011,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 85 | 21,009,123 | 21 M to 21 M (+0.02 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 34 | 21,004,123 | 21 M to 21 M (+0.01 %) |
Apr 12 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 9 | 21,002,123 | 21 M to 21 M (0.00 %) |
Apr 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 85 | 26,788,897 | 26.8 M to 26.8 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 22,001,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,996,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,995,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 18 | 21,993,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,992,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 21,991,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 21,986,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 87 | 21,981,623 | 22 M to 22 M (+0.02 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,976,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,975,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 36 | 21,974,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 17 | 21,972,623 | 22 M to 22 M (0.00 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 36 | 21,971,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 36 | 21,969,623 | 22 M to 22 M (+0.01 %) |
Apr 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,967,623 | 22 M to 22 M (+0.01 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 36 | 21,965,623 | 22 M to 22 M (+0.01 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,963,623 | 22 M to 22 M (+0.01 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,961,623 | 22 M to 22 M (+0.01 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,000 | 18 | 26,959,623 | 27 M to 27 M (0.00 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,958,623 | 22 M to 22 M (+0.01 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 182 | 21,956,623 | 21.9 M to 22 M (+0.05 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 181 | 21,946,623 | 21.9 M to 21.9 M (+0.05 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 91 | 21,936,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 91 | 21,931,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 182 | 21,926,623 | 21.9 M to 21.9 M (+0.05 %) |
Mar 28 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 92 | 21,916,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 94 | 26,783,897 | 26.8 M to 26.8 M (+0.02 %) |
Mar 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 94 | 26,778,897 | 26.8 M to 26.8 M (+0.02 %) |
Mar 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 92 | 26,773,897 | 26.8 M to 26.8 M (+0.02 %) |
Mar 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 92 | 26,768,897 | 26.8 M to 26.8 M (+0.02 %) |
Mar 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 2,000 | 42 | 23,763,897 | 23.8 M to 23.8 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 2,000 | 42 | 26,761,897 | 26.8 M to 26.8 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 2,000 | 42 | 26,761,897 | 26.8 M to 26.8 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 95 | 21,911,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,906,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,904,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 94 | 21,902,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,897,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,895,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 40 | 21,893,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 39 | 21,891,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 41 | 21,889,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 39 | 21,887,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 950 | 19 | 21,885,623 | 21.9 M to 21.9 M (0.00 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 50 | 1 | 21,884,673 | 21.9 M to 21.9 M (0.00 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 10,000 | 197 | 21,884,623 | 21.9 M to 21.9 M (+0.05 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,874,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 1,900 | 36 | 21,872,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 100 | 2 | 21,870,723 | 21.9 M to 21.9 M (0.00 %) |
Mar 22 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,870,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 100 | 21,868,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 103 | 21,863,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,858,623 | 21.9 M to 21.9 M (0.00 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,858,123 | 21.9 M to 21.9 M (0.00 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 95 | 21,857,623 | 21.9 M to 21.9 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,852,623 | 21.9 M to 21.9 M (+0.01 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 39 | 21,850,623 | 21.8 M to 21.9 M (+0.01 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 102 | 21,848,623 | 21.8 M to 21.8 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 100 | 21,843,623 | 21.8 M to 21.8 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 100 | 21,838,623 | 21.8 M to 21.8 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 105 | 21,833,623 | 21.8 M to 21.8 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 104 | 21,828,623 | 21.8 M to 21.8 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 108 | 21,823,623 | 21.8 M to 21.8 M (+0.02 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,818,623 | 21.8 M to 21.8 M (+0.01 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,816,623 | 21.8 M to 21.8 M (0.00 %) |
Mar 20 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 37 | 21,816,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 39 | 21,814,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 96 | 21,812,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,807,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,805,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,803,123 | 21.8 M to 21.8 M (0.00 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 38 | 21,802,623 | 21.8 M to 21.8 M (+0.01 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 500 | 10 | 21,800,623 | 21.8 M to 21.8 M (0.00 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 105 | 21,800,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 14 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 39 | 21,795,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 10,000 | 194 | 26,759,897 | 26.7 M to 26.8 M (+0.04 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 10,000 | 194 | 26,759,897 | 26.7 M to 26.8 M (+0.04 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 95 | 21,749,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 95 | 21,749,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 1,000 | 19 | 21,744,897 | 21.7 M to 21.7 M (0.00 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 1,000 | 19 | 21,744,897 | 21.7 M to 21.7 M (0.00 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 97 | 21,743,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 97 | 21,743,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 98 | 21,738,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 98 | 21,738,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 104 | 21,733,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 104 | 21,733,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 109 | 21,728,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 109 | 21,728,897 | 21.7 M to 21.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 2,000 | 44 | 26,723,897 | 26.7 M to 26.7 M (+0.01 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 2,000 | 44 | 26,723,897 | 26.7 M to 26.7 M (+0.01 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 112 | 26,721,897 | 26.7 M to 26.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 112 | 26,721,897 | 26.7 M to 26.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 2,000 | 44 | 26,716,897 | 26.7 M to 26.7 M (+0.01 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 2,000 | 44 | 26,716,897 | 26.7 M to 26.7 M (+0.01 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 1,000 | 22 | 26,714,897 | 26.7 M to 26.7 M (0.00 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 1,000 | 22 | 26,714,897 | 26.7 M to 26.7 M (0.00 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 104 | 26,713,897 | 26.7 M to 26.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 104 | 26,713,897 | 26.7 M to 26.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 112 | 26,708,897 | 26.7 M to 26.7 M (+0.02 %) |
Mar 13 2019 | ENDV | ENDONOVO THERAPEUT ... | Mann Michael Scott | President | Buy | P | 0.02 | 5,000 | 112 | 26,708,897 | 26.7 M to 26.7 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 102 | 21,793,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 3,000 | 60 | 21,788,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 39 | 21,785,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 99 | 21,783,123 | 21.8 M to 21.8 M (+0.02 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 2,000 | 40 | 21,778,123 | 21.8 M to 21.8 M (+0.01 %) |
Mar 08 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.02 | 5,000 | 99 | 21,776,123 | 21.8 M to 21.8 M (+0.02 %) |